Summary
DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company’s major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring systems. DexCom’s in-hospital product, GlucoClear, is a blood-based in-vivo automated glucose monitoring system. It also provides training and support services. DexCom offer its products to endocrinologists, physicians, diabetes educators and others. The company distributes its products in the US, Canada, Australia, New Zealand, Europe, Asia, Latin America and the Middle East through direct sales force and a network of distributors. DexCom is headquartered in San Diego, California, the US.
DexCom Inc (DXCM) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
DexCom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
DexCom Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
DexCom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
DexCom Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
DexCom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
DexCom Inc, Medical Equipment, Deal Details 11
Venture Financing 11
DexCom Raises USD7.2 Million in Venture Financing 11
Partnerships 11
Dexcom Enters into Licensing Agreement with Google Life Sciences 11
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 12
Tandem Diabetes Enters Into Licensing Agreement With DexCom 13
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 14
Glooko Enters into Agreement with Dexcom 15
Julphar Enters Into Co-Marketing Agreement With Dexcom 15
Roche Diagnostics Enters Into Distribution Agreement With DexCom 16
Roche Diagnostics Enters Into Research And Development Agreement With DexCom 17
Equity Offering 18
DexCom Completes Public Offering Of Common Stock For US$71.4 Million 18
Acquisition 19
DexCom to Acquire Nintamed 19
DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To US$8.5 Million 20
DexCom Inc - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Nov 14, 2016: Diabetes Management Leader Dexcom Expands Presence in EMEA Markets with new Edinburgh HQ 25
Jun 20, 2016: Dexcom to Expand Manufacturing Operations to Greater Phoenix, Arizona 26
Financial Announcements 27
Feb 28, 2017: DexCom Reports Fourth Quarter and Fiscal Year 2016 Financial Results 27
Jan 10, 2017: DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and Provides Initial 2017 Outlook 28
Nov 01, 2016: DexCom Reports Third Quarter 2016 Financial Results 29
Aug 02, 2016: DexCom Reports Second Quarter 2016 Financial Results 30
Apr 27, 2016: DexCom Reports First Quarter 2016 Financial Results 31
Feb 23, 2016: DexCom Reports Fourth Quarter and Full Year 2015 Financial Results 32
Corporate Communications 33
Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors 33
Product News 34
03/14/2016: Dexcom G5 Mobile Continuous Glucose Monitoring System Now Available on the Apple Watch 34
Other Significant Developments 35
Oct 20, 2016: Actor Derek Theler and Dexcom Take Center Stage to Raise Awareness of Diabetes 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
DexCom Inc, Medical Equipment, Key Facts, 2016 1
DexCom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
DexCom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
DexCom Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
DexCom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
DexCom Inc, Deals By Market, 2011 to YTD 2017 9
DexCom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
DexCom Raises USD7.2 Million in Venture Financing 11
Dexcom Enters into Licensing Agreement with Google Life Sciences 11
Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 12
Tandem Diabetes Enters Into Licensing Agreement With DexCom 13
Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 14
Glooko Enters into Agreement with Dexcom 15
Julphar Enters Into Co-Marketing Agreement With Dexcom 15
Roche Diagnostics Enters Into Distribution Agreement With DexCom 16
Roche Diagnostics Enters Into Research And Development Agreement With DexCom 17
DexCom Completes Public Offering Of Common Stock For US$71.4 Million 18
DexCom to Acquire Nintamed 19
DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To US$8.5 Million 20
DexCom Inc, Key Competitors 22
DexCom Inc, Key Employees 23
DexCom Inc, Subsidiaries 24
List of Figures
DexCom Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
DexCom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
DexCom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
DexCom Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
DexCom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
DexCom Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
DexCom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
DexCom Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9